Daniel O’Day became chairman and CEO of the US-based biopharmaceutical company Gilead Sciences, Inc. in March 2019 after John Milligan’s resignation from the post. Gilead’s headquarters is in Foster City, California. He helped company sail through the COVID-19 turmoil and came up with the first approved antiviral Remdesivir. Since the time he joined this high-profile […]